Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Bertolotti

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 16, 2025
Modifications in hemoglobin levels associated with age in an outpatient population from northern italyMarco Bertolotti, Tommaso Pirotti, Giulia Isha Castellani Tarabini, et al.
Clinical Interventions in Aging|July 9, 2021
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older PatientsCarlotta Franchi, Giulia Lancellotti, Marco Bertolotti, et al.
European Heart Journal. Acute Cardiovascular Care|July 5, 2023
Intrarenal Venous Doppler as a novel marker for optimal decongestion, patient management, and prognosis in Acute Decompensated Heart FailureFabrizio Turrini, Matteo Galassi, Andrea Sacchi, et al.
Minerva Cardioangiologica|June 2, 2017
Effects of Cholecalciferol Supplementation in Patients with stable heart failure and LOw vITamin D levels (ECSPLOIT-D): a double-blind, randomized, placebo-controlled pilot studyFabrizio Turrini, Stefania Scarlini, Paolo Giovanardi, et al.
Nutrients|February 2, 2021
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (<i>Bifidobacterium longum</i> BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)Stefania Cicolari, Chiara Pavanello, Elena Olmastroni, et al.
Journal of Gastroenterology and Hepatology|July 29, 2005
Gallstone disease in non-alcoholic fatty liver: prevalence and associated factorsPaola Loria, Amedeo Lonardo, Silvia Lombardini, et al.
Clinical Medicine Insights. Case Reports|December 19, 2013
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein eRiccardo Magistroni, Marco Bertolotti, Luciana Furci, et al.
World Journal of Gastroenterology|September 29, 2006
Fatty liver, carotid disease and gallstones: a study of age-related associationsAmedeo Lonardo, Silvia Lombardini, Federica Scaglioni, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorptionMarco Bertolotti, Lisa Zambianchi, Lucia Carulli, et al.
Drugs & Aging|March 17, 2017
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) StudyMarco Bertolotti, Carlotta Franchi, Marco B L Rocchi, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 16, 2025
Modifications in hemoglobin levels associated with age in an outpatient population from northern italyMarco Bertolotti, Tommaso Pirotti, Giulia Isha Castellani Tarabini, et al.
Clinical Interventions in Aging|July 9, 2021
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older PatientsCarlotta Franchi, Giulia Lancellotti, Marco Bertolotti, et al.
European Heart Journal. Acute Cardiovascular Care|July 5, 2023
Intrarenal Venous Doppler as a novel marker for optimal decongestion, patient management, and prognosis in Acute Decompensated Heart FailureFabrizio Turrini, Matteo Galassi, Andrea Sacchi, et al.
Minerva Cardioangiologica|June 2, 2017
Effects of Cholecalciferol Supplementation in Patients with stable heart failure and LOw vITamin D levels (ECSPLOIT-D): a double-blind, randomized, placebo-controlled pilot studyFabrizio Turrini, Stefania Scarlini, Paolo Giovanardi, et al.
Nutrients|February 2, 2021
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (<i>Bifidobacterium longum</i> BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)Stefania Cicolari, Chiara Pavanello, Elena Olmastroni, et al.
Journal of Gastroenterology and Hepatology|July 29, 2005
Gallstone disease in non-alcoholic fatty liver: prevalence and associated factorsPaola Loria, Amedeo Lonardo, Silvia Lombardini, et al.
Clinical Medicine Insights. Case Reports|December 19, 2013
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein eRiccardo Magistroni, Marco Bertolotti, Luciana Furci, et al.
World Journal of Gastroenterology|September 29, 2006
Fatty liver, carotid disease and gallstones: a study of age-related associationsAmedeo Lonardo, Silvia Lombardini, Federica Scaglioni, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorptionMarco Bertolotti, Lisa Zambianchi, Lucia Carulli, et al.
Drugs & Aging|March 17, 2017
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) StudyMarco Bertolotti, Carlotta Franchi, Marco B L Rocchi, et al.
Pageof 5